Sun Pharma launches FEXUCLUE (Fexuprazan) in India for treatment of Erosive Esophagitis EP News Bureau Apr 7, 2025 Under license from Korea’s Daewoong Pharmaceutical, Sun Pharma introduces FEXUCLUE, a potassium-competitive acid blocker for…
Zydus, Daewoong sign licensing pact to develop, market Leuprolide long-acting injectable in US EP News Bureau Dec 11, 2023 Leuprolide acetate for depot suspension is a GnRH agonist used for the treatment of advanced prostatic cancer, endometriosis, and…
Daewoong Pharma gets CDSCO nod to test anti-parasite drug for COVID-19 Reuters Aug 11, 2020 The South Korean drugmaker is testing the drug in partnership with Mankind Pharma which will continue the second and third phases…
